The Neuro Experience Neuroscientist: Why Women Are Being Sold Untested Brain Drugs (The Peptide Lie)
33 snips
Feb 10, 2026 Women in midlife are being targeted with untested peptide treatments marketed for brain fog, muscle loss, and joint pain. The conversation highlights the lack of randomized human trials, quality and safety failures in gray‑market peptides, and theoretical cancer or immune risks. Evidence-backed alternatives like resistance training, protein, sleep, and properly timed hormone therapy are emphasized as real brain‑protective strategies.
AI Snips
Chapters
Transcript
Episode notes
TB500's Mechanism Raises Safety Questions
- TB500 is a fragment of thymosin beta-4 with zero human data for deep tissue injections.
- Louisa Nicola notes its cell migration/proliferation action raises theoretical cancer-related concerns.
GH Secretagogues Inflate Mass, Not Strength
- Growth-hormone secretagogues can raise IGF-1 and worsen insulin sensitivity without functional strength gains.
- Louisa Nicola cites trials showing increased lean mass but no strength improvements and metabolic harms.
Gray-Market Peptides Are Frequently Mislabelled
- Gray-market peptide products often contain wrong doses, impurities, or different compounds.
- Louisa Nicola reports third-party tests showing many products lack the labeled active ingredient or purity.